These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 754366)

  • 41. [Acute manifestations of retinopathies].
    PAULO FILHO
    Rev Bras Oftalmol; 1952 Mar; 10(3):157-71. PubMed ID: 14958097
    [No Abstract]   [Full Text] [Related]  

  • 42. [Considerations about vascular retinopathies].
    MOREU
    Archivos Soc Oftalmol Hisp Am; 1949 May; 9(5):537. PubMed ID: 18145446
    [No Abstract]   [Full Text] [Related]  

  • 43. [Relationship Between Blood Dyscrasias and Retinopathies].
    AGATSTON SA
    Arch Oftalmol B Aires; 1945; 20():320-2. PubMed ID: 21007807
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of capillary density and function measures with blood pressure, fasting plasma glucose, and insulin sensitivity.
    Cheng C; Daskalakis C; Falkner B
    J Clin Hypertens (Greenwich); 2010 Feb; 12(2):125-35. PubMed ID: 20167040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies.
    Stefansson E; Landers MB; Wolbarsht ML
    Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML; Landers MB
    Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
    Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
    Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinal neovascularization.
    WISE GN
    Trans Am Ophthalmol Soc; 1956; 54():729-826. PubMed ID: 13433795
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia.
    ASHTON N; WARD B; SERPELL G
    Br J Ophthalmol; 1954 Jul; 38(7):397-432. PubMed ID: 13172417
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of tumor angiogenesis mediated by cartilage.
    Brem H; Folkman J
    J Exp Med; 1975 Feb; 141(2):427-39. PubMed ID: 1113064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of neovascularization by an extract derived from vitreous.
    Preis I; Langer R; Brem H; Folkman J
    Am J Ophthalmol; 1977 Sep; 84(3):323-8. PubMed ID: 900228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors of neovascularization in relation to diabetic and other proliferative retinopathies.
    Patz A; Lutty G; Bennett A; Coughlin WR
    Trans Am Ophthalmol Soc; 1978; 76():102-7. PubMed ID: 754366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal detachment associated with proliferative retinopathies (sickle cell disease, retrolental fibroplasia and diabetes mellitus).
    Goldberg MF
    Isr J Med Sci; 1972; 8(8):1447-57. PubMed ID: 4567302
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.